Free Daily Headlines :

  • COVID-19
  • Vaccine Info
  • Money
  • Politics
  • Education
  • Health
  • Justice
  • More
    • Environment
    • Economic Development
    • Gaming
    • Investigations
    • Social Services
    • TRANSPORTATION
  • Opinion
    • CT Viewpoints
    • CT Artpoints
DONATE
Reflecting Connecticut’s Reality.
    COVID-19
    Vaccine Info
    Money
    Politics
    Education
    Health
    Justice
    More
    Environment
    Economic Development
    Gaming
    Investigations
    Social Services
    TRANSPORTATION
    Opinion
    CT Viewpoints
    CT Artpoints

LET�S GET SOCIAL

Show your love for great stories and out standing journalism

CT, 38 other states widen probe of opioid manufacturers, distributors

  • Health
  • by Mackenzie Rigg
  • September 19, 2017
  • View as "Clean Read" "Exit Clean Read"

Kyle Constable :: CTMirror.org file photo

Attorney General George Jepsen

Attorneys general from 39 states, including Connecticut, have broadened an investigation into whether pharmaceutical manufacturers and distributors have played a role in the opioid epidemic, Connecticut Attorney General George Jepsen said Tuesday.

Calling it a “dramatic expansion and coordination of the investigations,” Jepsen said the coalition of attorneys general has sent investigative subpoenas to five manufacturers, including Stamford-based Purdue Pharma, the maker of the pain-killer OxyContin. The group also sent letters to three distributors requesting information.

“This is a major public health crisis nationally and in Connecticut,” Jepsen said. “For every person who dies, there’s dozens of lives that are ripped apart by this … This is an issue that certainly merits a commitment of resources from my staff and a lot of my time.” 

Connecticut joined the multi-state investigation this summer, but didn’t disclose then what companies the group was looking at. Since then, the coalition has broadened its scope. Connecticut, unlike some other states, has not sued any drug companies over potential involvement in the opioid epidemic.

Jepsen said Tuesday the group is investigating whether manufacturers changed their marketing practices to doctors to encourage the use of opioids not just for acute pain, but also for chronic pain, and, “if doing so, did they overstate the benefits and understate the risks of addiction?”

He said drug distributors are mandated under federal law to monitor who they sell their products to and to report any anomalies they come across. He said distributors have showed signs of improvement in their monitoring, but “there’s a question to whether they were asleep at the wheel” in previous years and whether “they are doing enough today.”

In Connecticut, the chief medical examiner has projected more than a thousand people will die from drug overdoses this year. That number has tripled since 2012, when 357 people died from overdoses.

“We share the attorneys’ general concern about the opioid crisis, and we are cooperating with their request,” said a Purdue spokesman in an email. “This is a multifaceted public health challenge, and we look forward to working collaboratively with government entities to be part of the solution.”

The other manufacturers sent investigative subpoenas were Endo International plc; Janssen Pharmaceuticals; Teva Pharmaceutical Industries Ltd./Cephalon Inc.; and Allergan Inc., according to Jepsen’s office.

Janssen spokesman William Foster said in a statement that the company had received and planned to address the request from the attorneys general.

“Janssen has acted responsibly and in the best interests of patients and physicians with regard to these medicines, which are FDA-approved and carry FDA-mandated warnings about possible risks on every product label,” Foster said.

Endo spokeswoman Heather Zoumas Lubeski said in an email that the company doesn’t comment on current litigation or investigations.

But she added that Endo shared “the FDA’s goal of appropriately supporting the needs of patients with chronic pain while preventing misuse and diversion of opioid products.”

The three distributors sent letters requesting information were AmerisourceBergen, Cardinal Health and McKesson. The three companies manage about 90 percent of the United States’s opioid distribution, Jepsen’s office said.

After Tuesday’s announcement, John M. Gray, president and CEO of the HealthCare Distribution Alliance, said in a statement that, “Distributors have no ability to influence what prescriptions are written. The fact is that distributors don’t make medicines, market medicines, prescribe medicines or dispense them to consumers. Our role is to deliver medicines safely, securely and efficiently from manufacturers to pharmacies, hospitals and other healthcare institutions based on prescriptions written by licensed prescribers.”

Gabe Weissman, AmerisourceBergen spokesman, said in an email that the company had “taken extensive action to help ensure the safe and secure delivery of these drugs, including reporting suspicious orders to the Drug Enforcement Agency and stopping tens of thousands of suspicious orders from being shipped.”

A spokeswoman from McKesson said the company is “committed to maintaining—and continuously improving—strong programs designed to detect and prevent opioid diversion within the pharmaceutical supply chain.”

A number of states, counties and cities nationwide have sued various drug companies, alleging they are partially to blame for the epidemic.

Waterbury has filed a suit and 12 municipalities have signed retainers to join the suit — New Milford, Roxbury, Bristol, Naugatuck, Wolcott, Bridgeport, Oxford, Southington, Prospect, Woodbury, East Hartford and Southbury — according to the Waterbury’s mayor’s office.

Sign up for CT Mirror's free daily news summary.

Free to Read. Not Free to Produce.

The Connecticut Mirror is a nonprofit newsroom. 90% of our revenue comes from people like you. If you value our reporting please consider making a donation. You'll enjoy reading CT Mirror even more knowing you helped make it happen.

YES, I'LL DONATE TODAY

ABOUT THE AUTHOR

Mackenzie Rigg

SEE WHAT READERS SAID

RELATED STORIES
Aid-in-dying bill clears key hurdle with committee passage
by Jenna Carlesso

The bill would let terminally ill patients access medication to end their lives.

With billions in federal relief on the way to CT, legislators assert their role in deciding how to spend it
by Keith M. Phaneuf and Mark Pazniokas

With an unusual bill, state legislators are reminding Gov. Ned Lamont they have significant role in disbursing federal coronavirus relief.

How does the public option bill differ from Gov. Ned Lamont’s health care plan? Here’s a look at the two proposals.
by Jenna Carlesso

With the rising cost of care a central issue this legislative session, lawmakers and Gov. Ned Lamont’s administration have each moved ahead with their own plans aimed at driving down prices.

Medical providers are taking nature therapy seriously
by Jenifer Frank | C-HIT.ORG

In a time of social isolation and staying home, sometimes a walk in the park is the best medicine.

Have a case of a COVID variant? No one is going to tell you
by Christina Jewett and JoNel Aleccia | Kaiser Health News and Rachana Pradhan

Federal rules around who can be told about the variant cases are confusing, and tests have not been approved.

Support Our Work

Show your love for great stories and outstanding journalism.

$
Select One
  • Monthly
  • Yearly
  • Once
Artpoint painter
CT ViewpointsCT Artpoints
Opinion The public health bill no one is talking about, but should be
by Brian Festa

On February 16,  the legislature's Public Health Committee conducted a public hearing on two bills, S.B. 568 and H.B. 6423, both of which would eliminate the religious exemption to mandatory vaccinations for Connecticut schoolchildren.  The hearing was capped at 24 hours, depriving nearly 1,500 members of the public who had registered for the hearing their opportunity to be heard.  The vast majority of those who did testify, and who submitted written testimony, opposed the bill.  The committee is expected to vote on the bill as early as  today. 

Opinion Students need more resources, fewer officers
by Tenille Bonilla

"School resource officer" is just a nice way to say cop. But what students really need is more resource and less officer.

Opinion The Board of Regents’ changes must not shortchange its students or faculty
by Carrie Andreoletti, PhD

As a university professor and a lifespan developmental psychologist, I tend to approach my work from a developmental perspective. This means I aim to foster a lifelong love of learning and to help others find a sense of meaning and purpose, as well as confidence in their ability to reach their goals. My approach to higher education is shaped by my desire to provide the best possible education for my students. This is why the recent Board of Regents’ proposed changes at the four state universities have me worried.

Opinion How to close schooling opportunity gaps created by the pandemic
by Carol Gale

We ask school district leaders to trust your public servants whose daily work life involves assessing student needs and planning or modifying instruction to meet those needs. Listen to their voices, as we have, and allocate precious resources on interventions that will offer increased opportunities for Hartford students to succeed.

Artwork Grand guidance
by Anne:Gogh

In a world of systemic oppression aimed towards those of darker skintones – representation matters. We are more than our equity elusive environments, more than numbers in a prison and much more than victims of societal dispositions. This piece depicts a melanated young man draped in a cape ascending high above multiple forms of oppression. […]

Artwork Shea
by Anthony Valentine

Shea is a story about race and social inequalities that plague America. It is a narrative that prompts the question, “Do you know what it’s like to wake up in new skin?”

Artwork The Declaration of Human Rights
by Andres Chaparro

Through my artwork I strive to create an example of ideas that reflect my desire to raise social consciousness, and cultural awareness. Jazz music is the catalyst to all my work, and plays a major influence in each piece of work.”

Artwork ‘A thing of beauty. Destroy it forever’
by Richard DiCarlo | Derby

During times like these it’s often fun to revisit something familiar and approach things with a different slant. I have been taking some Pop culture and Art masterpieces and applying the vintage 1960’s and 70’s classic figures (Fisher Price, little people) to the make an amusing pieces. Here is my homage to Fisher -Price, Yellow […]

Twitter Feed
A Twitter List by CTMirror

Engage

  • Reflections Tickets & Sponsorships
  • Events
  • Donate
  • Newsletter Sign-Up
  • Submit to Viewpoints
  • Submit to ArtPoints
  • Economic Indicator Dashboard
  • Speaking Engagements
  • Commenting Guidelines
  • Legal Notices
  • Contact Us

About

  • About CT Mirror
  • Announcements
  • Board
  • Staff
  • Sponsors and Funders
  • Donors
  • Friends of CT Mirror
  • History
  • Financial
  • Policies
  • Strategic Plan

Opportunity

  • Advertising and Sponsorship
  • Speaking Engagements
  • Use of Photography
  • Work for Us

Go Deeper

  • Steady Habits Podcast
  • Economic Indicator Dashboard
  • Five Things

The Connecticut News Project, Inc. 1049 Asylum Avenue, Hartford, CT 06105. Phone: 860-218-6380

© Copyright 2021, The Connecticut News Project. All Rights Reserved. Website by Web Publisher PRO